An additional strength of our study compared with previous MR studies that set out to investigate associations between breast cancer risk factors and the hormone receptor subtypes is that we maximized the statistical power of our primary analyses through the inclusion of as many genetic IVs as possible in combination with LD matrices. The gene discussed is NR4A1; the disease is breast carcinoma.